like us on facebook connect with us on linkedin follow us on twitter August 08, 2018

Welcome to the Reimbursement Bulletin

MSHO Confidentiality Statement

We recommend you view the Bulletin in your web browser. At the very top, it says, "To view this bulletin in a web browser, click here." 

This Bulletin will be published semi-monthly.  As always, any comments, suggestions, stories or questions can be sent to billing@msho.org. We hope you enjoy this issue!

Section Header

A Message From Your Bulletin Sponsor

Merck

~ Merck’s KEYTRUDA® (pembrolizumab) Plus Pemetrexed (ALIMTA®) and Platinum Chemotherapy Reduced the Risk of Death by Half Compared with Chemotherapy Alone as First-Line Treatment for Advanced Nonsquamous NSCLC in Phase 3 KEYNOTE-189 Study

Details >

Important Oncology Related News

~ UnitedHealthcare Reminder: National Drug Code (NDC) Requirement Policy
~ ASCO Summary of the Proposed Rule for the CY 2019 Medicare Physician Fee Schedule and Quality Payment Program
~ The Proposed 2019 E&M Overhaul: A Preliminary Financial Impact Analysis
~ CMS Empowers Patients and Ensures Site-Neutral Payment in Proposed Rule
~ Radiation Oncology Proposed Rule Summary by ASTRO

Details >
Section Header

MSHO Reimbursement Alerts

~ Update on Denials from WPS Medicare for Treanda, J9033
~ Outpatient Hospital Denials for ESAs

Details >

MSHO's Fall Reimbursement Meeting

Wednesday, October 17, 2018

Schoolcraft College - Livonia, MI
SAVE THE DATE!

Details >

MSHO's Medical Oncology Reimbursement 101 Webinar

Wednesday, July 25, 2018

Recording and handouts are available on the MSHO website!

Details >
Section Header

MSHO Featured Corporate Sponsor Assistance Program

SeattleGenetics

~ Oncology-related products: Adcetris® (brentuximab vedotin)

Details >

PAN Foundation Updates

~ Co-pay Accumulator Programs
~ Pan Foundation Provider Newsletter

Details >
Section Header

WPS Oncology Related LCD Updates

August 2018

Including...
~ CMS Re-work of the National Coverage Determination for ESAs Still Pending - NO UPDATE
~ WPS LCD changes related to ESA Q-codes, HIFU in the treatment of Recurrent Prostate Cancer, MolDX changes, Added C9467 for Rituximab and hyaluronidase human, 10 mg (for outpatient hospital use only)

Details >

WPS Recent Oncology Related News

Part A, Part B and Part A/B News

Articles that may be of interest to oncology which were released in the past 2 weeks.

Details >

Join WPS for a Teleconference, Webinar or Seminar!

Check out these upcoming training events....

Including....
~ Evaluation and Management Webinar - 08/14/18 Documentation
~ Webinar - 08/14/18 Evaluation and Management Services: Documentation Examples
~ Webinar - 08/15/18 WPS GHA Learning Center Changes
~ Webinar - 09/12/18 CERT Overview
~ Teleconference - 09/19/18 Waivers to Extend Timely Filing
PLUS many more educational opportunities!

Details >
Section Header

Michigan RAC Information

Region 1 - Performant Recovery, Inc.

August 2018 - No New Updates

Details >

Recent RAC Monitor Articles

This edition includes articles on......

~ Responses to Proposed E&M Code Changes Emerge: CMS, Are You Listening?
~ News Alert: CMS Posts 2019 IPPS Final Rule, Heralding Major Changes to Admission Order Regulation

Details >

CMS-Medicare

Recent Oncology Related Articles

~ As MACRA Heads Toward Third Year, Congress Urged to Consider How Proposed CMS Changes Will Impact Medicare Beneficiaries with Cancer
~ CMS Grants New Technology Add-On Payment to Vyxeos® (daunorubicin and cytarabine) Liposome for Injection
~ Qualified Medicare Beneficiary Program Billing Requirements FAQs
~ 2018 QRDA III Implementation Guide for Eligible Professionals
~ Physician Fee Schedule Proposed Rule: Understanding 3 Key Topics Listening Session – August 22
~ Provider Minute Video: Physician Orders/Intent to Order Laboratory Services and Other Diagnostic Services
~ PECOS Technical Assistance Contact Information Fact Sheet
~ E/M Coding Reform: Recording of Panel Discussion
~ CLFS and Laboratory Services Payment: Quarterly Update MLN Matters Article

Details >
Section Header

BCBSM/BCN

Recent Oncology Related News

~ Commercial Medical Drug Prior Authorization Program adds 3 groups, as of Sept. 1
~ Medicare Advantage compliance audits to begin Oct. 1
~ Additional fee schedules added to web-DENIS
~ Starting Oct. 1, additional specialty medications require authorization for BCN Advantage members
~ Billing chart: Blues highlight medical, benefit policy changes
~ We’ve canceled the modifier 25 payment adjustment for evaluation and management services
~ New radiation oncology program benefits providers offering ‘gold standard’ of care
~ Register for a medical specialty drug prior-authorization web tool refresher course
~ Effective Oct. 1, Prolia® and Xgeva® are subject to a site-of-care requirement for BCN HMOSM members

Details >
Section Header

Payer Issue Tracking Page

Last Updated 8/7/18

Review the reported payer reimbursement issues MSHO is currently addressing...
~Priority Health Split Claims Causing Rejections **RESOLVED - Priority Has Agreed To Remove The Edit Effective Immediately!!!
~ WPS Medicare Doing Take Backs on Treanda, J9033

Details >

Medicaid

Recent Oncology Related Issues and News

Medicaid Advantage Pending Issues; Meridian approving Neulasta! Also, in this update..... Public Comment on MDHHS Medicaid Health Plan Common Formulary, MSA Bulletins, Biller "B" Aware Notices

Details >

Priority Health

News Updates

~ Priority removed requirement to submit all services on one single claim
~ Medicare chart reviews starting soon
~ Request elective retrospective authorizations through Clear Coverage starting Aug. 15

Details >

Medicare Plus Blue

System Updates

~ Many updates/corrections. Listed below is a sampling of what you will find...
****Voided claims are incorrectly denying as duplicates
****Claims are denying against the Medicare 72 hour rule
****Coinsurance and reimbursement are applying incorrect rates for rural health center claims
****Specialty versus primary care physician copayments, wrong copay applied
****and more...

Details >

Newsletters of Interest

~ Aetna OfficeLink Updates
~ BCN Provider News
~ Cigna
~ HAP/HealthPlus ProviderPlus
~ Humana YourPractice
~ UHC NetworkBulletin
~ UHC Medical Policy Update

Details >

Managed Care Committee Reimbursement TIDBITS

Featuring this month: Aetna/Cofinity

~ Online Manual for Health Care Professionals
~ 180 Day Dispute Filing Standard
~ Drug Infusion Site of Care Policy

Details >
Section Header

Recent Oncology Related Drug News

~ TAILORx: Many Women With Early Breast Cancer Can Avoid Chemotherapy
~ FDA Discontinues Iclusig® REMS Program
~ Eisai and Merck Announce FDA Grants Breakthrough Therapy Designation for LENVIMA® (lenvatinib) in Combination with KEYTRUDA® (pembrolizumab) as Therapy for Previously Treated Patients with Advanced and/or Metastatic non-MSI-H/pMMR Endometrial Carcinoma
~ Celgene Bows To White House Pressure After Raising Prices For Cancer Drug

Details >
Section Header

Recent Oncology Related News

~ Be Counted: Complete the 2018 ASCO Practice Census Today
~ MIPS Scoring Guide: How to succeed under the new CMS payment model
~ News Alert: 2019 ICD-10-CM Coding Guidelines Have Been Released

Details >
Section Header

ASK MSHO

August 2018, Frequently Asked Questions

Topics Include:
~ Office Visit Coding Changes for 2019
~ Nurse Practitioner Education
~ Visit New Patient vs Established Patient
~ Free Transportation for Chemotherapy Appointments

Details >